Maurer Toby
Department of Dermatology, University of California-San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, Building 90, Ward 92, #224, San Francisco, CA 94110, USA.
Dermatol Clin. 2004 Jul;22(3):321-4, vii. doi: 10.1016/j.det.2004.03.019.
As the risk of bioterrorism becomes an increasingly significant issue in the United States and the world, dermatologists have found themselves as partners or front line participants in the effort to prepare for and respond to such a threat. In what was previously an unfamiliar part of practice for most dermatologists, bioterrorism has required that providers familiarize themselves with the pathophysiology, clinical presentation, diagnosis,and management of diseases from agents that could potentially be used.
随着生物恐怖主义风险在美国乃至全球日益成为一个重大问题,皮肤科医生发现自己已成为应对此类威胁的准备和响应工作中的合作伙伴或一线参与者。对于大多数皮肤科医生来说,生物恐怖主义曾是他们业务中一个陌生的领域,它要求医疗人员熟悉可能被用作生物制剂引发的疾病的病理生理学、临床表现、诊断及治疗方法。